Scalpers operating in the so-called “gray market” are profiteering from recent drug shortages by amassing medicines - including cancer drugs - in high demand and then re-selling them at preposterously high prices to hospitals desperate to provide life-saving treatments for their patients, according to a Congressional investigation led by Rep. Elijah Cummings (D-Md.). Read more at WhatTheFolly.com.
